Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4501 AL 4515

Progress in the development of naturally derived active metabolites-based drugs: Potential therapeutics for Alzheimer's disease

Mani R, Sha Sulthana A, Muthusamy G, Elangovan N.

Biotechnol Appl Biochem. 2022 Dec;69(6):2713-2732. doi: 10.1002/bab.2317. Epub 2022 Feb 8.

A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?

Küpeli Akkol E, Bardakcı H, Yücel Ç, Şeker Karatoprak G, Karpuz B, Khan H.

Oxid Med Cell Longev. 2022 Jan 12;2022:6168199. doi: 10.1155/2022/6168199. eCollection 2022.

Recent Insights on Glutamatergic Dysfunction in Alzheimer's Disease and Therapeutic Implications

Pinky PD, Pfitzer JC, Senfeld J, Hong H, Bhattacharya S, Suppiramaniam V, Qureshi I, Reed MN.

Neuroscientist. 2023 Aug;29(4):461-471. doi: 10.1177/10738584211069897. Epub 2022 Jan 25.

Amyloid β interaction with model cell membranes - What are the toxicity-defining properties of amyloid β?

Mrdenovic D, Pieta IS, Nowakowski R, Kutner W, Lipkowski J, Pieta P.

Int J Biol Macromol. 2022 Mar 1;200:520-531. doi: 10.1016/j.ijbiomac.2022.01.117. Epub 2022 Jan 21.

Adult Hippocampal Neurogenesis in Alzheimer's Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery

Farioli-Vecchioli S, Ricci V, Middei S.

Neural Plast. 2022 Jan 15;2022:9959044. doi: 10.1155/2022/9959044. eCollection 2022.

Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

De Sousa RAL, Improta-Caria AC.

Metab Brain Dis. 2022 Mar;37(3):559-580. doi: 10.1007/s11011-022-00903-y. Epub 2022 Jan 25.

Exploring the dual character of metformin in Alzheimer's disease

Ning P, Luo A, Mu X, Xu Y, Li T.

Neuropharmacology. 2022 Apr 1;207:108966. doi: 10.1016/j.neuropharm.2022.108966. Epub 2022 Jan 22.

Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease

Bera A, Lavanya G, Reshmi R, Dev K, Kumar R.

Eur J Neurosci. 2022 Nov;56(9):5516-5531. doi: 10.1111/ejn.15611. Epub 2022 Feb 12.

Functional insight into LOAD-associated microglial response genes

Jonas LA, Jain T, Li YM.

Open Biol. 2022 Jan;12(1):210280. doi: 10.1098/rsob.210280. Epub 2022 Jan 26.

Protein degradation-associated mechanisms that are affected in Alzheimer´s disease

Tecalco-Cruz AC, Pedraza-Chaverri J, Briones-Herrera A, Cruz-Ramos E, López-Canovas L, Zepeda-Cervantes J.

Mol Cell Biochem. 2022 Mar;477(3):915-925. doi: 10.1007/s11010-021-04334-8. Epub 2022 Jan 27.

Tau protein aggregation: Key features to improve drug discovery screening

Giovannini J, Smeralda W, Jouanne M, Sopkova-de Oliveira Santos J, Catto M, Voisin-Chiret AS.

Drug Discov Today. 2022 May;27(5):1284-1297. doi: 10.1016/j.drudis.2022.01.009. Epub 2022 Jan 24.

Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing

Vitória JJM, Trigo D, da Cruz E Silva OAB.

Cell Mol Life Sci. 2022 Jan 28;79(2):101. doi: 10.1007/s00018-021-04090-4.

Advances in prodrug design for Alzheimer's disease: the state of the art

Travers-Lesage V, Mignani SM, Dallemagne P, Rochais C.

Expert Opin Drug Discov. 2022 Apr;17(4):325-341. doi: 10.1080/17460441.2022.2031972. Epub 2022 Feb 23.

Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

Gao L, Zhang Y, Sterling K, Song W.

Transl Neurodegener. 2022 Jan 28;11(1):4. doi: 10.1186/s40035-022-00279-0.

Regulatory decisions diverge over aducanumab for Alzheimer's disease

Lythgoe MP, Jenei K, Prasad V.

BMJ. 2022 Jan 28;376:e069780. doi: 10.1136/bmj-2021-069780.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias